Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
38743 POSTS 0 COMMENTS

January 2016 Briefing – Infectious Disease

0
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for January 2016. This roundup includes the...

January 2016 Briefing – HIV & AIDS

0
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for January 2016. This roundup includes...

January 2016 Briefing – Gastroenterology

0
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for January 2016. This roundup includes the latest...

January 2016 Briefing – Family Practice

0
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for January 2016. This roundup includes the...

January 2016 Briefing – Diabetes & Endocrinology

0
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for January 2016. This roundup includes...

January 2016 Briefing – Dermatology

0
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for January 2016. This roundup includes the latest...

January 2016 Briefing – Cardiology

0
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for January 2016. This roundup includes the latest...

January 2016 Briefing – Allergy

0
Here are what the editors at HealthDay consider to be the most important developments in Allergy for January 2016. This roundup includes the latest...
A beauty clay sold at major retail outlets may put users at risk for lead poisoning

FDA Warns of Lead Poisoning Risk From Cosmetic Clay

0
Agency tells users of Bentonite Me Baby to stop using product, get checked by their doctor
Zepatier (elbasvir and grazoprevir) has been approved by the U.S. Food and Drug Administration to treat chronic hepatitis C virus genotypes 1 and 4 infections.

FDA Approves Zepatier for Chronic Hepatitis C

0
Medication indicated for patients with hepatitis C virus genotypes 1 and 4 infections